1. Home
  2. JRSH vs MREO Comparison

JRSH vs MREO Comparison

Compare JRSH & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$5.32

Market Cap

41.9M

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.32

Market Cap

50.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JRSH
MREO
Founded
2016
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.9M
50.3M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
JRSH
MREO
Price
$5.32
$0.32
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$4.00
$1.50
AVG Volume (30 Days)
87.1K
4.8M
Earning Date
02-09-2026
05-11-2026
Dividend Yield
5.68%
N/A
EPS Growth
485.71
16.67
EPS
0.13
N/A
Revenue
$166,263,870.00
$500,000.00
Revenue This Year
$11.64
$5,184.20
Revenue Next Year
$10.06
$55.51
P/E Ratio
$41.00
N/A
Revenue Growth
14.03
N/A
52 Week Low
$2.85
$0.20
52 Week High
$5.60
$2.37

Technical Indicators

Market Signals
Indicator
JRSH
MREO
Relative Strength Index (RSI) 69.32 51.43
Support Level $3.05 $0.29
Resistance Level $5.47 $0.35
Average True Range (ATR) 0.30 0.03
MACD 0.05 0.00
Stochastic Oscillator 77.50 45.19

Price Performance

Historical Comparison
JRSH
MREO

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: